Aditya Birla Sun Life Nifty Healthcare ETF

An open ended exchange traded fund tracking Nifty Healthcare TRI
BSE Scrip Code: 543473 | Symbol: HEALTHY
 

Fund Category Exchange Traded Fund (ETF)

Investment Objective The investment objective of the scheme is to provide returns that before expenses, closely correspond to the total returns of securities as represented by Nifty Healthcare TRI, subject to tracking errors. However, the performance of scheme may differ from that of the underlying index due to tracking error.
The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Fund Details
Fund Manager: Mr. Haresh Mehta & Mr. Pranav Gupta
Managing Fund Since: March 31, 2023 & June 08, 2022
Experience in Managing the Fund: 0.2 Years & 1.0 Years
Date of Allotment: October 20, 2021
Type of Scheme: An open ended exchange traded fund tracking Nifty Healthcare TRI
Application Amount for
fresh subscription:
Min. Addl. Investment (Market Makers):		 The Creation Unit size for the scheme shall be 1,10,000 units and in multiples thereof.
NAV: 9.0152
Benchmark: Nifty Healthcare TRI
Monthly Average AUM: 28.22 Crores
AUM as on last day: 29.43 Crores
Load Structure (as % of NAV)
Entry Load: Nil
Exit Load: Nil
Total Expense Ratio (TER)
Including additional expenses and goods and service tax on management fees.
Regular 0.09%
Tracking Error
Regular 0.03%
Note: The exit load rate levied at the time of redemption/switch-out of units will be the rate prevailing at the time of allotment of the corresponding units. Customers may request for a separate Exit Load Applicability Report by calling our toll free numbers 1800-270-7000 or from any of our Investor Service Centers.
*Standard deviation of daily tracking difference computed for a 1 year horizon. If the fund is non-existent for 1 year then since inception returns are considered.

Data as on 30th June 2023 unless otherwise specified


Portfolio Holdings
Issuer
% to net Assets
Rating
Pharmaceuticals & Biotechnology 78.01%  
Sun Pharmaceutical Industries Limited 20.62%  
Dr. Reddys Laboratories Limited 11.39%  
Cipla Limited 9.67%  
Divi's Laboratories Limited 8.29%  
Lupin Limited 3.95%  
Aurobindo Pharma Limited 3.72%  
Torrent Pharmaceuticals Limited 3.16%  
Alkem Laboratories Limited 3.13%  
Zydus Lifesciences Limited 2.68%  
Laurus Labs Limited 2.62%  
Abbott India Limited 2.25%  
Biocon Limited 2.14%  
Glenmark Pharmaceuticals Limited 1.84%  
IPCA Laboratories Limited 1.81%  
Granules India Limited 0.73%  
Healthcare Services 21.91%  
Apollo Hospitals Enterprise Limited 9.32%  
Max Healthcare Institute Limited 8.04%  
Syngene International Limited 2.46%  
Dr. Lal Path Labs Limited 1.40%  
METROPOLIS HEALTHCARE LIMITED 0.69%  
Cash & Current Assets 0.08%  
Total Net Assets 100.00%  
  • Past performance may or may not be sustained in future. The above performance is of Regular Plan - Growth Option. Kindly note that different plans have different expense structure. Load and Taxes are not considered for computation of returns. When scheme/additional benchmark returns are not available, they have not been shown. Total Schemes Co-Managed by Fund Managers is 15. Total Schemes managed by Mr. Haresh Mehta is 16. Total Schemes managed by Mr. Pranav Gupta is 17. Click here to know more on performance of schemes managed by Fund Managers.


This page is a part of the July 2023 Factsheet of Aditya Birla Sun Life Mutual Fund. Click on http://empower.abslmf.com/ for the digital factsheet.

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.


pdf